UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. α-1アンチトリプシン欠乏の治療 treatment of alpha 1 antitrypsin deficiency
2. ステロイド5 -α-レダクターゼ2欠乏症 steroid 5 alpha reductase 2 deficiency
3. αサラセミアの病態生理 pathophysiology of alpha thalassemia
4. 原発性肝細胞癌の臨床的特徴および診断 clinical features and diagnosis of primary hepatocellular carcinoma
5. パーキンソン病の臨床症状 clinical manifestations of parkinson disease

Japanese Journal

Tanji Kunikazu,Mori Fumiaki,Wakabayashi Koichi,Kamitani Tetsu
弘前醫學 61(Supplement), S89-S96, 2010
… Synphilin-1 is anα-synuclein-interacting protein and is a major component of inclusion bodies found in the brains of patients withneurodegenerative α-synucleinopathies, including Parkinson’s disease. … In our recent studies, we immunostainedsections of brains from patients with Parkinson’s disease and other α-synucleinopathies and demonstrated thatNUB1, as well as synphilin-1, accumulates in the inclusion bodies. …
NAID 110007617028

＜Symposium III＞Pathology of neuro-glial α-synucleinopathy (Lewy body disease and multiple system atrophy)

Wakabayashi Koichi,Miki Yasuo,Tanji Kunikazu,Mori Fumiaki
弘前醫學 61(Supplement), S80-S88, 2010
… α-Synucleinopathies comprise a group of neurodegenerative disorders that share α-synuclein （αS）accumulation in selected vulnerable neurons and glia, i.e. Parkinson’s disease （PD）, dementia with Lewy bodies andmultiple system atrophy（ MSA）. …
NAID 110007616986